LMWH is as an inhibitor of the endothelial glycocalyx-degrading enzyme heparanase, which is well known to exacerbate vascular leakage and inflammation, and may be involved in the development of ARDS in COVID-19 [212]. This evidence concerns the gene HPSE and COVID-19.